Breecort Use In Pregnancy & Lactation

Pregnancy: Results from a large prospective epidemiological study and from world-wide post marketing experience indicate that inhaled budesonide during pregnancy has no adverse effects on the health of the fetus/newborn child.
As with other drugs, the administration of budesonide during pregnancy requires that the benefits for the mother are weighted against the risk for the fetus.
Lactation: Budesonide is excreted in breast milk. However, at therapeutic doses of budesonide, no effects on the suckling child are anticipated. Budesonide can be used during breastfeeding.
Maintenance treatment with inhaled budesonide (200 or 400 mcg twice daily) in asthmatic nursing women results in negligible exposure to budesonide in breast fed infants.